| [1] |
Torner A, Stokkeland K, Svensson,et al. The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence. Hepatology, 2017, 65: 885-892.
|
| [2] |
Goldberg DS, Taddei TH, Serper M, et al. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis. Hepatology, 2017, 65:864-874.
|
| [3] |
Davila JA, Morgan RO, Richardson PA,et al. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology, 2010, 52:132-41.
|
| [4] |
Dalton-Fitzgerald E, Tiro J, Kandunoori P, et al. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol, 2015, 13:791-8 e1.
|
| [5] |
McGowan CE, Edwards TP, Luong MUT,et al. Suboptimal surveillance for and knowledge of hepatocellular carcinoma among primary care providers. Clin Gastroenterol Hepatol, 2015, 13: 799-804.
|
| [6] |
Farvardin S, Patel J, Khambaty M, et al. Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis. Hepatology, 2017, 65: 875-884.
|
| [7] |
Beste LA, Ioannou GN, Yang Y,et al. Improved surveillance for hepatocellular carcinoma with a primary care-oriented clinical reminder. Clin Gastroenterol Hepatol, 2015, 13:172-179.
|
